$4.31
Edesa Biotech is a biotechnology business based in the US. Edesa Biotech shares (EDSA) are listed on the NASDAQ and all prices are listed in US Dollars. Edesa Biotech employs 16 staff and has a trailing 12-month revenue of around $500.
Our top picks for where to buy Edesa Biotech stock
How to buy Edesa Biotech stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – EDSA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Edesa Biotech stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Edesa Biotech stock price (NASDAQ: EDSA)
Use our graph to track the performance of EDSA stocks over time.Edesa Biotech shares at a glance
Latest market close | $4.30 |
---|---|
52-week range | $2.46 - $6.46 |
50-day moving average | $4.59 |
200-day moving average | $4.48 |
Wall St. target price | $20.50 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-19.78 |
Is it a good time to buy Edesa Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Edesa Biotech price performance over time
Historical closes compared with the close of $4.3 from 2024-09-03
1 week (2024-08-29) | -4.44% |
---|---|
1 month (2024-08-05) | -9.47% |
3 months (2024-06-05) | -7.53% |
6 months (2024-03-05) | -2.49% |
1 year (2023-09-05) | 394.25% |
---|---|
2 years (2022-09-02) | 144.32% |
3 years (2021-09-03) | 5.8 |
5 years (2019-09-05) | 5.98 |
Edesa Biotech financials
Revenue TTM | $500 |
---|---|
Gross profit TTM | $311,200 |
Return on assets TTM | -71.52% |
Return on equity TTM | -129.29% |
Profit margin | 0% |
Book value | $0.88 |
Market Capitalization | $14.6 million |
TTM: trailing 12 months
Edesa Biotech share dividends
We're not expecting Edesa Biotech to pay a dividend over the next 12 months.
Have Edesa Biotech's shares ever split?
Edesa Biotech's shares were split on a 1:7 basis on 10 October 2023. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Edesa Biotech shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Edesa Biotech shares which in turn could have impacted Edesa Biotech's share price.
Edesa Biotech share price volatility
Over the last 12 months, Edesa Biotech's shares have ranged in value from as little as $2.46 up to $6.46. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Edesa Biotech's is 0.801. This would suggest that Edesa Biotech's shares are less volatile than average (for this exchange).
Edesa Biotech overview
Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 2b clinical study to treat chronic allergic contact dermatitis. The company also develops EB02, an extension of secretory phospholipase 2 anti-inflammatory cream for treating erythema, swelling, and exudation associated with hemorrhoids disease; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada. .
Frequently asked questions
nullWhat percentage of Edesa Biotech is owned by insiders or institutions?
Currently 33.967% of Edesa Biotech shares are held by insiders and 11.871% by institutions. How many people work for Edesa Biotech?
Latest data suggests 16 work at Edesa Biotech. When does the fiscal year end for Edesa Biotech?
Edesa Biotech's fiscal year ends in September. Where is Edesa Biotech based?
Edesa Biotech's address is: 100 Spy Court, Markham, ON, Canada, L3R 5H6 What is Edesa Biotech's ISIN number?
Edesa Biotech's international securities identification number is: CA27966L1085 What is Edesa Biotech's CUSIP number?
Edesa Biotech's Committee on Uniform Securities Identification Procedures number is: 85855A104
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question